Sodium (R)-2,3-bis(((9Z,12Z)-octadeca-9,12-dienoyl)oxy)propyl (2,3-dihydroxypropyl) phosphate

Catalog No. :
ACSEMV172
CAS No. :
322729-38-4
Molecular Formula :
C42H74NaO10P
Molecular Weight :
793.01

IUPAC Name:sodium (R)-2,3-bis(((9Z,12Z)-octadeca-9,12-dienoyl)oxy)propyl (2,3-dihydroxypropyl) phosphate

Sodium (R)-2,3-bis(((9Z,12Z)-octadeca-9,12-dienoyl)oxy)propyl (2,3-dihydroxypropyl) phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium (R)-2,3-bis(((9Z,12Z)-octadeca-9,12-dienoyl)oxy)propyl (2,3-dihydroxypropyl) phosphate
IUPAC Namesodium (R)-2,3-bis(((9Z,12Z)-octadeca-9,12-dienoyl)oxy)propyl (2,3-dihydroxypropyl) phosphate
Molecular FormulaC42H74NaO10P
Molecular Weight793.01
SMILESO=P(OC[C@H](OC(CCCCCCC/C=C\C/C=C\CCCCC)=O)COC(CCCCCCC/C=C\C/C=C\CCCCC)=O)(OCC(O)CO)[O-].[Na+]
InChI KeyZIOOVFPFWVCCEB-WDFQPZSRSA-M
Synonym322729-38-4 | Sodium (2R)-2,3-bis{[(9Z,12Z)-octadeca-9,12-dienoyl]oxy}propyl 2,3-dihydroxypropyl phosphate | sodium;[(2R)-2,3-bis[[(9Z,12Z)-octadeca-9,12-dienoyl]oxy]propyl] 2,3-dihydroxypropyl phosphate | DTXSID30677103 | 18:2 PG, 1,2-dilinoleoyl-sn-glycero-3-ph
CAS No.322729-38-4
PubChem CID46891832

Synthetic Route by SureRoute

1. ACSEMV172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAKNJ147 route compound structure diagram
    ACAKNJ14760-33-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSEMV172 route product structure diagram
    ACSEMV172322729-38-4
Inquiry

2. ACSEMV172 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSEMV172 route product structure diagram
    ACSEMV172322729-38-4
Inquiry

Comments (0)